TP53 and neuroblastoma: The present panel included 8 MYCN amplified and 8 non-MYCN amplified p53 wt neuroblastoma cell lines (Table 1), and there was a non-significant trend for MYCN amplified cell lines to be more sensitive to RG7388 (P = 0.087, Welch t test, Supplementary Figure 1B).